Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics
Y Duan, K Gong, S Xu, F Zhang, X Meng… - Signal Transduction and …, 2022 - nature.com
Disturbed cholesterol homeostasis plays critical roles in the development of multiple
diseases, such as cardiovascular diseases (CVD), neurodegenerative diseases and …
diseases, such as cardiovascular diseases (CVD), neurodegenerative diseases and …
Vascular dementia
JT O'Brien, A Thomas - The Lancet, 2015 - thelancet.com
Vascular dementia is one of the most common causes of dementia after Alzheimer's
disease, causing around 15% of cases. However, unlike Alzheimer's disease, there are no …
disease, causing around 15% of cases. However, unlike Alzheimer's disease, there are no …
Cholesterol metabolism in neurodegenerative diseases: molecular mechanisms and therapeutic targets
L Dai, L Zou, L Meng, G Qiang, M Yan, Z Zhang - Molecular neurobiology, 2021 - Springer
Cholesterol is an indispensable component of the cell membrane and plays vital roles in
critical physiological processes. Brain cholesterol accounts for a large portion of total …
critical physiological processes. Brain cholesterol accounts for a large portion of total …
[HTML][HTML] Promoting successful cognitive aging: a ten-year update
A decade has passed since we published a comprehensive review in this journal
addressing the topic of promoting successful cognitive aging, making this a good time to …
addressing the topic of promoting successful cognitive aging, making this a good time to …
Statin use and risk of dementia or Alzheimer's disease: a systematic review and meta-analysis of observational studies
E Olmastroni, G Molari, N De Beni… - European journal of …, 2022 - academic.oup.com
Aims As the potential impact of statins on cognitive decline and dementia is still debated, we
conducted a meta-analysis of observational studies to examine the effect of statin use on the …
conducted a meta-analysis of observational studies to examine the effect of statin use on the …
Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention
C Qiu, M Kivipelto, E Von Strauss - Dialogues in clinical …, 2009 - Taylor & Francis
More than 25 million people in the world today are affected by dementia, most suffering from
Alzheimer's disease. In both developed and developing nations, Alzheimer's disease has …
Alzheimer's disease. In both developed and developing nations, Alzheimer's disease has …
Alzheimer's disease
K Blennow, MJ de Leon, H Zetterberg - The Lancet, 2006 - thelancet.com
Alzheimer's disease is the most common cause of dementia. Research advances have
enabled detailed understanding of the molecular pathogenesis of the hallmarks of the …
enabled detailed understanding of the molecular pathogenesis of the hallmarks of the …
[HTML][HTML] Alzheimer disease
RJ Castellani, RK Rolston, MA Smith - Disease-a-month: DM, 2010 - ncbi.nlm.nih.gov
In 1907, Alois Alzheimer described the case of a 51 year old woman who presented with a
relatively rapidly deteriorating memory along with psychiatric disturbances. She died four …
relatively rapidly deteriorating memory along with psychiatric disturbances. She died four …
Statins for the prevention of dementia
B McGuinness, D Craig, R Bullock… - Cochrane database of …, 2009 - cochranelibrary.com
Background This is an update of a Cochrane review first published in 2001. At that stage
there was insufficient evidence to recommend statins for the prevention of Alzheimer's …
there was insufficient evidence to recommend statins for the prevention of Alzheimer's …
Cholesterol: its regulation and role in central nervous system disorders
M Orth, S Bellosta - Cholesterol, 2012 - Wiley Online Library
Cholesterol is a major constituent of the human brain, and the brain is the most cholesterol‐
rich organ. Numerous lipoprotein receptors and apolipoproteins are expressed in the brain …
rich organ. Numerous lipoprotein receptors and apolipoproteins are expressed in the brain …